UV irradiation can act as a tumor initiator in mouse skin, yet repetitive UV irradiation can systemically prevent chemically induced two-stage skin tumorigenesis. The present study addressed the question of whether repetitive dorsal UV irradiation would enhance or inhibit subsequent initiation and promotion applied dorsally. Approximately 4.25 x 10(5) J/m2 was applied intermittently to 30 shaved CDF1 mice over an 8 week period. Mice were then initiated dorsally with 100 micrograms of 7,12-dimethylbenz[a]anthracene and subsequently promoted with 7.5 micrograms 12-O-tetradecanoylphorbol-13-acetate (TPA) applied twice weekly for 19 weeks. Initiated and promoted mice that had been treated repetitively with 1.06 x 10(4) J/m2 showed a decrease in tumor incidence from 92 to 28%, and a reduction in tumor yield per mouse from 5.35 to 0.58, at 19 weeks after the first TPA treatment. Histological analysis revealed that the UVB radiation treatments used in these experiments did not produce permanent loss of epidermal cells or sebaceous gland atrophy. When the same dose of UVB irradiation was applied after initiation and promotion, no increased conversion of papillomas to carcinomas was found, within a 48 weeks experimental duration. Thus, repetitive UV irradiation prevented rather than enhanced subsequent two-stage tumorigenesis. Repetitive UVB irradiation at late stages of promotion failed to enhance conversion of papillomas to carcinomas within the time frame in which chemical initiators mediate conversion to malignancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/carcin/13.1.9 | DOI Listing |
Sci Rep
December 2024
Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Avenida Cataluña, 21, 46020, Valencia, Spain.
Improvement of post-stroke outcomes relies on patient adherence and appropriate therapy maintenance by physicians. However, comprehensive evaluation of these factors is often overlooked. This study assesses secondary stroke prevention by differentiating patient adherence to antithrombotic treatments (ATT) from physician-initiated interruptions or switches.
View Article and Find Full Text PDFSignal Transduct Target Ther
December 2024
Department of Orthopedic Surgery/Sports Medicine Center, Southwest Hospital, Army Medical University, Chongqing, 400038, China.
Metabolites can double as a signaling modality that initiates physiological adaptations. Metabolism, a chemical language encoding biological information, has been recognized as a powerful principle directing inflammatory responses. Cytosolic pH is a regulator of inflammatory response in macrophages.
View Article and Find Full Text PDFPhotochem Photobiol
December 2024
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Pathogens can be involved in tumor initiation, promotion, and progression through different mechanisms, and their treatment can prevent new cancer cases, improve outcomes, and revert poor-prognostic phenotypes. Photodynamic therapy (PDT) successfully treats different types of cancers and infections and, therefore, has a unique potential to address their combination. However, we believe this potential has been underutilized, and few researchers have investigated the impacts of PDT of both infection-related and cancer-related outcomes at once.
View Article and Find Full Text PDFSmall
December 2024
State Key Laboratory of Oral Diseases, School of Chemical Engineering, National Center for Stomatology & National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, 610041, China.
Intractable implant-associated infections (IAIs) are the primary cause of prosthetic implant failure, particularly in the context of diabetes mellitus. There is an urgent need to design and construct versatile engineered implants integrated with cascade amplification therapeutic modality to significantly improve the treatment of diabetic IAIs. To address this issue, a multi-functional MXene/AgPO@glucose oxidase bio-heterojunction enzyme (M/A@GOx bio-HJzyme) coating is developed, which is decorated with an inert sulfonated polyetheretherketone implant (SP-M/A@G) via hydrothermal treatment and layered deposition.
View Article and Find Full Text PDFFront Oncol
December 2024
Department of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Background: Preoperative determination of muscular infiltration is crucial for appropriate treatment planning in patients with muscle-invasive bladder cancer (MIBC). We aimed to explore early diagnostic biomarkers in serum for MIBC in this study.
Methods: The expression profiles of long noncoding RNA (lncRNA) were initially screened by high-throughput sequencing and evaluation of potential lncRNAs were conducted by two phases of RT-qPCR assays using serum samples from 190 patients with MIBC and 190 non-muscle-invasive BC (NMIBC) patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!